Pharmasintez will create the production of cardiological drugs in the Tyumen region

The company “Pharmasintez” will create a large production of cardiological drugs in the Tyumen region, the volume of investments in the project will be more than 4 billion rubles. The corresponding agreement on Thursday at the St. Petersburg International Economic Forum (SPIEF) was signed by the governor of the region Alexander Moor and the president of Pharmasintez Vikram Singh Punia. According to the head of the region, the new import substitution production will close 20% of Russia’s need for medicines for the treatment of cardiovascular diseases. The volume of investments in the project will amount to more than 4 billion rubles, it is planned to create about 200 new jobs.